Gemcitabine + Capecitabine
Sponsors
Swiss Cancer Institute, Klinikum der Universitaet Muenchen, Grosshadern, Vejle Hospital, Albert Einstein College of Medicine, Australasian Gastro-Intestinal Trials Group
Conditions
CancerMetastatic Colorectal CancerPancreatic CancerPancreatic Cancer ResectableResected Pancreatic Adenocarcinoma
Phase 1
Carbon Ion Radiation Therapy for Locally Advanced Pancreatic Cancer
CompletedNCT03403049
Start: 2016-04-01End: 2019-07-09Updated: 2020-04-22
Personalized Tumor Neoantigen MRNA Therapy Adjuvant Treatment for Postoperative Pancreatic Cancer.
Not yet recruitingNCT06888674
Start: 2025-04-01End: 2029-04-01Target: 60Updated: 2025-03-21
Phase 2
A Phase II Study of Gemcitabine and Capecitabine for Treatment Resistant, Metastatic Colorectal Cancer
CompletedNCT01472770
Start: 2011-10-31End: 2014-05-31Updated: 2014-12-04
MFOLFIRINOX And Stereotactic Radiotherapy (SBRT) for Pancreatic Cancer With High Risk and Locally Advanced Disease
NCT04089150
Start: 2019-10-01End: 2023-08-30Target: 120Updated: 2021-10-22